Attempts to reduce the toxicity of hematopoietic stem cell transplantation have led to the use of various immunosuppressive, yet nonmyeloablative preparative regimens that often include low-dose irradiation. To determine the effects of low-dose irradiation on the dynamics of donor cell engraftment after bone marrow transplantation (BMT), we coupled standard endpoint flow cytometric analysis with in vivo longitudinal bioluminescence imaging performed throughout the early (\10 days) and late (days 10-90) post-BMT periods. To exclude the contribution of irradiation on reducing immunologic rejection, severely immune-deficient mice were chosen as recipients of allogeneic bone marrow. Flow cytometric analysis showed that sublethal doses of total body irradiation (TBI) significantly increased long-term (14 weeks) donor chimerism in the bone marrow compared with nonirradiated recipients (P \ .05). Bioluminescence imaging demonstrated that the effect of TBI (P \ .001) on chimerism occurred only after the first 7 days post-BMT. Flow cytometric analysis on day 3 showed no increase in the number of donor cells in irradiated bone marrow, confirming that sublethal irradiation does not enhance marrow chimerism early after transplantation. Local irradiation also significantly increased late (but not early) donor chimerism in the irradiated limb. Intrafemoral injection of donor cells provided efficient early chimerism in the injected limb, but long-term systemic donor chimerism was highest with i.v. administration (P \.05). Overall, the combination of TBI and i.v. administration of donor cells provided the highest levels of long-term donor chimerism in the marrow space. These findings suggest that the major effect of sublethal irradiation is to enhance long-term donor chimerism by inducing proliferative signals after the initial phase of homing.
INTRODUCTION
In classic preparative regimens for allogeneic bone marrow transplantation (BMT), patients receive full myeloablative conditioning and immune suppression to achieve complete hematopoietic reconstitution with donor cells. The toxicity associated with high-dose radiation and chemotherapy excludes many patients from receiving this necessary treatment, however. High levels of bone marrow chimerism also have been achieved using nonmyeloablative conditioning regimens that focus mostly on immune suppression [1] [2] [3] . Several rodent models of nonmyeloablative BMT have demonstrated that engraftment can be enhanced by increasing the donor cell dose [4] , changing the route of cell administration [5] , or increasing immunologic suppression to prevent rejection [6, 7] .
Most clinical nonmyeloablative preparative regimens include low-dose irradiation [8] . The mechanism through which low-dose radiation acts to improve engraftment remains controversial. Although lethal irradiation is believed to create ''space'' in the stem cell niche, the most primitive hematopoietic stem cells are relatively resistant to irradiation [9] . Thus, low-dose irradiation is often considered to aid engraftment through lymphoablation. An intriguing finding using a murine congenic transplantation model was that highdose irradiation of a local area of marrow increased engraftment both locally and at distal sites, suggesting that at least high doses of irradiation enhance engraftment independent of immunologic barriers [10] .
The central goal of the present work was to assess the effect of sublethal irradiation provided as either total body irradiation (TBI) or local irradiation, on the process of engraftment. Severely immune-deficient mice (nonobese diabetic [NOD] severe combined immune-deficient [SCID] IL-2Rgnull, also known as NSG) were used as recipients to exclude the contribution of irradiation on immunologic rejection of allogeneic bone marrow. In addition to absent T and B cell development from the SCID mutation, the NOD mutation results in abnormal macrophage and dendritic cell function, and the IL2Rg null mutation results in natural killer (NK) cell deficiency. Thus, severe defects exist in both the adaptive and innate immune systems of NSG mice [11] .
Engraftment is a process resulting from a combination of early homing and lodging of donor stem cells to the recipient endosteal niche, with subsequent proliferation and redistribution throughout the marrow spaces [12] [13] [14] . Engraftment can be measured in vivo by quantifying the number of donor cells circulating in the recipient's peripheral blood. But this method does not accurately determine the chimerism of donor hematopoietic stem cells in the recipient bone marrow and is limited by the number of repeat bleeds from a single animal. The standard quantitative measurement of donor chimerism in the marrow cavity uses flow cytometric analysis of cells isolated from the bone marrow of euthanized animals. Although very sensitive, this type of analysis is poorly suited for longitudinal studies of engraftment patterns. In the present study, we combined endpoint flow cytometry with a noninvasive bioluminescence imaging approach developed in our laboratory [15] to study the effect of sublethal irradiation on the dynamics of early and late donor cell engraftment in immune-deficient mice.
MATERIALS AND METHODS

Animals
Transgenic donor mice (Caliber Life Science, Hopkinton, MA) and NOD/SCID/IL-2gc -/recipients (NSG) mice (Jackson Laboratories, Bar Harbor, ME) were kept in separate pathogen-free facilities under approved protocols of the Children's Hospital Los Angeles Institutional Animal Care and Use Committee.
BMT
Mononuclear bone marrow cells from FVB mice (H-2K q ) ubiquitously expressing luciferase under the b-actin promoter were transplanted into 8-to 10week-old NSG recipients (H-2Kq). Recipients were sublethally irradiated with a dose of 2.7 Gy to the whole body (TBI) or locally to the right hind limb (RHL-IR) before BMT. Whole bone marrow cells were injected directly into the right or left femur (intrafemoral) or i.v. through the tail vein using a 28-gauge needle.
Irradiation
TBI was administered using a MK-1-68A cesium-137 gamma animal irradiator (J.L. Shepherd & Associates, San Fernando, CA) or a Clinac 2100C 6-MV X-ray linear accelerator (Varian Medical Systems, Palo Alto, CA). Local irradiation to the right hind limb was accomplished by placing the limbs of the anesthetized animal within a single radiation field encompassing the entire hind limb, including the femoral head but not the pelvis. A 1.5-cm-thick layer of artificial tissue was used to build up the dose to the midplane of the leg to 2.7 Gy in a single dose. The radiation dose at 0.5 cm outside the field border was \10% of the central dose.
Flow Cytometric Analysis of Multilineage Engraftment
Mice were euthanized at 3 days or 10-14 weeks after BMT by inhalation of a 75% CO 2 /25% O 2 mixture. Hematopoietic cells were harvested from the left and right femurs, spleen, and peripheral blood of each animal. Single-cell suspensions were stained in 1% fetal bovine serum in phosphate-buffered saline. Flow cytometry data were acquired with a FACSCalibur flow cytometer (BD Bioscience, Franklin Lakes, NJ) and analyzed using FlowJo software (Tree Star, Inc., Ashland, OR). Cells were initially gated using the forward and side-scatter distribution profile of hematopoietic cells to eliminate any contribution from debris, before analysis of donor chimerism by monoclonal antibodies against mouse H-2K q (BD Pharmingen, San Diego, CA). Contribution of each hematopoietic lineage was determined using CD11b (monocyte), Ly-6c/g (granulocyte), CD33 (T cell), B220 (B cell), and NK1.1 (NK cell) (BD Pharmingen).
Bioluminescence Imaging
Mice were imaged serially beginning 24 hours after transplantation (day 1) as follows. A 125-mg/kg dose of luciferin (Promega, Madison, WI) diluted in phosphatebuffered saline was introduced by i.p. injection 8 minutes before imaging. Mice were anesthetized with 2%-3% isoflurane with oxygen in an induction chamber, then placed into a Xenogen IVIS 100 imaging system (Caliber Life Sciences) and maintained under anesthesia during image acquisition. Acquisition time began at 3 minutes each on the ventral and dorsal surfaces of each animal and was decreased to 1 minute after 1 week and then to 1 second after 1 month because of camera photon saturation. Data were analyzed using the Living Image 2.5 software included with the imaging system. With this software, regions of interest were drawn around the whole body and the right and left hind limb of each mouse to determine the donor cell bioluminescence, measured in photons/second/cm 2 /steradian. Negative control mice were injected with saline solution instead of cells at the time of initial injection. During imaging, negative controls were used to determine the threshold for detection of luciferase-specific bioluminescence.
Statistical Analysis
Statistical analysis was performed with Prism software (GraphPad Software, Inc, La Jolla, CA). Data are presented as mean 6 standard error of the mean (SEM). Before statistical analysis, data were transformed logarithmically to allow the use of parametric tests because of the small sample size of each group. The unpaired t test was used for comparing 2 groups of flow cytometry data. One-way analysis of variance (ANOVA) using Bonferroni's multiple-comparison posttest was used for flow cytometry data with 3 or more groups. Two-way ANOVA using Bonferroni's multiple-comparison posttest was used to analyze longitudinal bioluminescence data at each time point. Early chimerism was analyzed by combining repeated measurements for each animal within each group for the first 10 days after BMT, followed by a paired t test (for hind limb bioluminescence) or unpaired t test (for whole-body bioluminescence). Late chimerism was analyzed by combining repeated measurements for each animal within each group after 10 days post-BMT, followed by a paired t test (for hind limb bioluminescence) or unpaired t test (for wholebody bioluminescence).
RESULTS
Sublethal TBI Increases Long-Term Donor Chimerism
To evaluate the effect of sublethal irradiation on donor cell engraftment, severely immune-deficient mice underwent transplantation with a range of doses of wild-type donor bone marrow cells in the presence or absence of sublethal (2.7 Gy) TBI. Immunedeficient mice were used as recipients to eliminate any contribution of immune rejection from the process of engraftment. At 14 weeks after BMT, recipient mice were euthanized, and cells were harvested from bone marrow, spleen, and peripheral blood to assess donor cell chimerism by flow cytometry based on expression of the donor major histocompatibility complex class I type H-2K q in recipient tissue ( Figure 1 ).
Sublethal irradiation significantly increased donor chimerism in the bone marrow compared with nonir-radiated recipients (69% 6 5%, compared with 6% 6 3% in mice receiving 1 Â 10 6 donor cells; P \.05) at 14 weeks after BMT ( Figure 1A ). As expected, in irradiated animals, the level of bone marrow chimerism was correlated with cell dose; however, in nonirradiated animals, bone marrow chimerism was at equivalent low levels with all cell doses tested.
Reconstitution of all the hematopoietic lineages from the donor cells was examined by flow cytometry using antibodies against common mouse lineage markers for macrophages, granulocytes, B cells, T cells, and NK cells. Donor chimerism in the bone marrow was predominantly from myeloid lineages ( Figure 1A) , and irradiation mainly affected myeloid engraftment. BMT with wild-type donor bone marrow restored the predominantly lymphoid distribution of lineages in the NSG spleen, all of which were, as expected, of donor origin ( Figure 1B ). Based on the levels of donor chimerism and the lineage makeup of the chimerism, the donor cells found to be circulating in the peripheral blood presumably reflected the contributions from engraftment of donor cells in the marrow and the subsequent donor-derived lymphopoiesis in the immune-deficient host thymus and spleen ( Figure 1C ). Thus, in the severely immune-deficient host, sublethal irradiation significantly increased long-term bone marrow chimerism predominantly of myeloid lineage.
Longitudinal Analysis of Donor Cell Engraftment in Recipients with or without Sublethal TBI Using Bioluminescence Imaging
To analyze the effects of sublethal irradiation on the rate of engraftment, transgenic mice expressing the firefly luciferase gene in all hematopoietic cells were used as bone marrow donors. This permitted the use of bioluminescence imaging to quantify relative levels of chimerism longitudinally at various time points after BMT. Consistent with the flow cytometry data shown in Figure 1 , sublethal irradiation increased long-term stable chimerism at all cell doses tested (1 Â 10 6 , P \.001; 1 Â 10 5 , P \.01; 1 Â 10 4 , P \.05) (Figure 2A-2C ). In contrast, early levels of donor chimerism (defined as days 1-10 post-BMT) rose rapidly, reaching similar levels irrespective of whether or not irradiation was given (Figure 2A -2C); only after the first week was donor chimerism significantly increased by irradiation. Irradiated and nonirradiated recipients undergoing BMT at all cell doses had significantly higher bioluminescence compared with background levels in negative control (ie, nontransplanted) mice ( Figure 2D and 2E).
Donor Chimerism During the Early Posttransplantation Period
The finding of similar levels of bioluminescence in the early posttransplantation period in irradiated and nonirradiated recipients suggests the presence of equivalent numbers of total donor cells regardless of irradiation therapy. Because the limited sensitivity of bioluminescence imaging might not allow for the detection of differences in low levels of engraftment, flow cytometric analysis was used to further analyze the effects of irradiation on donor chimerism during the early stages of engraftment. Again, immunedeficient mice received either no irradiation or 2.7 Gy of TBI before receiving 1 Â 10 6 wild-type bone marrow cells i.v. from luciferase transgenic mice. These recipients were sacrificed at 3 days or 7 days post-BMT to assess total cell counts isolated from the right femur using a hemacytometer. In addition to bone marrow, cells from the spleen were harvested from recipients 3 days post-BMT to assess donor cell chimerism by flow cytometric analysis of H-2K q -positive donor cells ( Figure 3 ).
Sublethal TBI significantly decreased (P \.001) the total number of cells (host plus donor) found in the femurs of recipients at 3 days and 7 days post-BMT ( Figure 3A ). Although the percentage of donor cells was increased in the femurs of irradiated recipients compared with nonirradiated recipients at 3 days post-BMT (2.8% 6 0.2% vs 0.8% 6 0.1%; Figure 3B ), when the total cellularity was taken into account, the marrow of irradiated animals was found to contain a lower number of donor cells than that of nonirradiated animals (1.3 6 0.5 Â 10 4 vs 8.2 6 1.5 Â 10 4 ; P 5 .002) ( Figure 3C ). In contrast, in the spleen, the total number of donor cells did not differ significantly between irradiated and nonirradiated recipients (6 6 2 Â 10 4 vs 7 6 1 Â 10 4 ; Figure 3D ).
Intrafemoral Injection Produces Lower Long-Term Donor Chimerism in Bone Marrow Than i.v. Administration of Donor Cells in Sublethally Irradiated Immune-Deficient Recipients
Several previous studies using xenogeneic transplantation models have reported that purified human stem cell and progenitor cell populations engraft immune-deficient mice more efficiently when injected Longitudinal analysis with bioluminescence imaging reveals a differential effect of sublethal irradiation on early versus late chimerism. Wholebody bioluminescence was measured in recipient mice after i.v. BMTwith luciferase-expressing transgenic donor cells beginning 24 hours after BMTand serially over the course of 96 days. Recipients received either no irradiation (NIR) or 2.7 Gy of TBI before i.v. injection of 1 Â 10 6 , 1 Â 10 5 , or 1 Â 10 4 donor whole bone marrow cells. A, Logarithmic graph of mean 6 SEM whole-body bioluminescence, measured in photons/second/cm 2 /steradian, plotted against days after BMT in recipients of TBI (n 5 6) and nonirradiated mice (n 5 3), showing only those that received 1 Â10 6 donor cells. B, Logarithmic plot of mean 6 SEM whole-body bioluminescence of recipients of TBI (n 5 2) and nonirradiated mice (n 5 1), showing only those that received 1 Â 10 5 donor cells. C, Logarithmic plot of mean 6 SEM whole-body bioluminescence in recipients of TBI (n 5 1) and nonirradiated mice (n 5 2), showing only those that received 1 Â 10 4 donor cells. Repeat bioluminescence measurements were combined for the first 10 days (early) or longer than 10 days post-BMT (late) before the unpaired t test for statistical significance was used to compare TBI recipients and nonirradiated mice at each cell dose (A-C). The P value for significance using the unpaired t test is given in each panel; NS indicates no statistical significance. TBI produced significantly higher late (but not early) chimerism at each cell dose studied. D, Logarithmic plot of mean whole-body bioluminescence against days post-BMT for all recipient groups. SEM is omitted for clarity. Data from control (nontransplanted) mice are shown in black, those from nonirradiated mice are shown in blue, and data from mice receiving TBI are shown in red. Within each group, a solid line indicates a transplanted cell dose of 1 Â 10 6 cells, a dashed line represents a dose of 1 Â 10 5 cells, and a dotted line represents a dose of 1 Â 10 4 cells. Two-way ANOVA with Bonferroni's multiplecomparison posttest for statistical significance (*P \.05; **P \.01) was used to compare each recipient group versus controls (n 5 5) at each time point. E, Representative images of donor cell bioluminescence in TBI, nonirradiated, and control recipient mice at 1, 4, 8, 14, and 96 days after BMT. TBI and nonirradiated mice received a dose of 1 Â 10 6 donor cells at BMT. In the right column, the images from each mouse at day 96 are scaled to decrease the signal intensity and more clearly demonstrate the anatomic distribution of chimerism in the mice that received TBI. All statistical analyses were performed on logarithmic transformation of the data combined from 3 experiments. NIR indicates no irradiation; NS, not statistically significant.
directly into the bone marrow, presumably by avoiding the problem of inefficient homing to marrow through the i.v. route [16, 17] . Thus, we tested whether intrafemoral injection of whole allogeneic bone marrow would also provide higher levels of engraftment compared with i.v. infusion in the sublethal irradiation setting. Surprisingly, intrafemoral injection did not increase long-term chimerism based on fluorescence-activated cell sorting (FACS) analysis of harvested tissues at 10 weeks post-BMT ( Figure 4 ). In fact, i.v. administration of donor cells produced significantly higher systemic marrow chimerism than that seen in animals given donor cells via direct intrafemoral injection (69% 6 3% vs 40% 6 10%; P \.05; Figure 4A ). Again, high levels of donor chimerism were seen in the spleen irrespective of the route of administration ( Figure 4B ).
Bioluminescence imaging demonstrated that i.v. infusion of donor marrow resulted in higher wholebody signal levels compared with intrafemoral injection at almost all stages of engraftment, although donor chimerism from intrafemoral administration gradually increased to i.v. levels by 10 weeks post-BMT ( Figure 5A and 5B) . Given that whole-body bioluminescence reflects donor cells, not only in the marrow, but also in the spleen and peripheral blood, local measurements of signal intensity in each hind limb were then analyzed to compare the dynamics of engraftment specifically in the marrow space with each route of administration. In animals given i.v. donor cell infusions, signal intensity was equivalent in each hind limb at all time points ( Figure 5C ), as would be expected with systemic administration. In animals in which marrow was injected directly into the right femur, early engraftment (up to 8 days) was higher in the injected limb than in the noninjected limb, after which time the signal intensity in both limbs increased to similar levels ( Figure 5D ). These findings suggest that mobilization of donor cells from the injected marrow and subsequent proliferation in distant sites delays equilibration of chimerism in all marrow niches. Thus, systemic chimerism increases more rapidly and efficiently when donor cells are given i.v., because although direct administration of donor cells into the marrow cavity produces early efficient engraftment in the local site of injection, redistribution to distal sites is delayed.
Sublethal TBI Produces Greater Long-Term Chimerism Than Local Irradiation: Intravenous BMT
A recent study found that local radiation increases long-term stable engraftment in both irradiated and nonirradiated sites compared with no irradiation [10] . However, this report did not address the question of whether local irradiation can provide similar levels of chimerism as that seen with TBI. Thus, we directly compared engraftment patterns after local irradiation of the right hind limb with those after TBI. After irradiation, recipients received luciferase-expressing donor bone marrow cells via i.v. injection into the tail vein, and chimerism was assessed as before by FACS analysis of bone marrow at 10 weeks post-BMT and longitudinally by bioluminescence imaging.
Donor chimerism was analyzed at 10 weeks post-BMT by flow cytometry of cells isolated separately from the right (irradiated) and left (nonirradiated) hind limbs. With i.v. administration of donor marrow, TBI provided significantly higher overall chimerism in marrow from both hind limbs compared with local irradiation of the right hind limb or no irradiation (TBI, 69% 6 3%; local irradiation, 7% 6 2%; no irradiation, 6% 6 2%; P \ .001) ( Figure 6A ). As expected, the nonirradiated and TBI-treated animals demonstrated no difference in levels of chimerism between the right hind limb and the left hind limb at 10 weeks post-BMT. Animals that received local irradiation to the right hind limb and i.v. marrow infusion showed a trend toward higher chimerism in the irradiated limb compared with the nonirradiated left limb at 10 weeks post-BMT (11% 6 3% vs 4% 6 1%), although the differences did not reach statistical significance.
Bioluminescence imaging of the same animals confirmed that after the first week post-BMT, systemic (whole-body) chimerism, as measured by the total bioluminescent signal of the whole animal, was significantly greater in mice that received TBI compared with mice that received either local irradiation or no irradiation ( Figure 6B ). Consistent with our previous data, the significant increase in chimerism seen with TBI was evident only after 7-10 days post-BMT. Local irradiation conferred no increase in systemic chimerism compared with no irradiation at any time point; however, when imaging was restricted to each hind limb, a significantly (P \ .05) higher signal was detected in the irradiated limb compared with the nonirradiated limb, with the effect seen only after . Shown are mean 6 SEM for the total percentage of donor cells, with different hematopoietic lineages as described in Figure 1A . ANOVA with Bonferroni's multiple-comparison posttest was used to determine the statistical significance comparing chimerism in the left hind limb and the right hind limb within and between recipient groups. Left and right hind limb data were combined and analyzed using the unpaired t test for statistical significance (*P \ .05) comparing systemic marrow engraftment in i.v. versus intrafemoral BMT. Statistical analysis was performed on logarithmic transformation of data from one representative experiment. Macs/grans indicates macrophages/granulocytes; NK, natural killer. 7-10 days post-BMT ( Figure 6E ). This indicates that local irradiation was significantly inferior to TBI in providing long-term chimerism after i.v. administration of bone marrow.
Sublethal TBI Produces Greater Long-Term Chimerism Than Local Irradiation: Intrafemoral BMT
To minimize any effect on homing, we next examined the effects of TBI versus local irradiation when donor cells were injected directly into the marrow cavity. For locally irradiated animals, donor cells were injected either into the irradiated (local) femoral cavity or into the nonirradiated (distal) femoral cavity. Again, donor chimerism at 10 weeks post-BMT was analyzed separately by flow cytometry of cells isolated from the right and left hind limbs. In all experiments using intrafemoral BMT, TBI produced significantly higher long-term marrow chimerism compared with local irradiation applied to the in-jected or noninjected limb (40% 6 10% with TBI vs 7% 6 3% with injection into the locally irradiated femur [P \.05] and vs 4% 6 1% with injection into the nonirradiated femur [P \.01]) ( Figure 6C ). Using TBI, chimerism did not differ in injected and noninjected limbs by 10 weeks post-BMT, consistent with the data shown in Figure 4 . When donor cells were injected into the same (right) limb that had been locally irradiated, the mean chimerism in the right injected limb was higher than that in the left noninjected, nonirradiated limb at 10 weeks post-BMT (11% 6 5% vs 2% 6 1%), although these differences did not reach statistical significance. When donor cells were injected into the distal (left) limb that had not been irradiated, the donor chimerism in both limbs was no different from that seen in nonirradiated animals. Thus, a small effect was seen with local irradiation only when bone marrow was infused directly into the irradiated site, not when marrow was infused distal to the irradiation. For animals that received either no irradiation (C and D; n 5 4) or TBI (C and D; n 5 5), intrafemoral administration was given into the right femur (RF-BMT). For animals that received local irradiation to the right hind limb, donor cells were injected either into the irradiated right femur (RF-BMT; C, D, and F; n 5 2) or into the nonirradiated left femur (LF-BMT; C, D, and G; n 5 3). A and C, % H-2K q -positive donor cells detected by flow cytometry from samples analyzed separately from the left and right femurs of recipient mice at 10 weeks post-BMT. ANOVA with Bonferroni's adjustment test (***P \ .001) were used to compare the left hind limb and right hind limb within each group and across each group. B and D, Logarithmic plots of mean whole-body bioluminescence versus days after i.v. (B) or intrafemoral BMT (D). Data for nonirradiated mice are shown in blue with solid circles, data for mice receiving TBI are shown in red with solid circles, and data for mice receiving irradiation to the right hind limb are shown with empty black circles with either a red line for right femur injection (RF-BMT) or a blue line for left femur injection (LF-BMT). The nonirradiated and LF-BMT data overlap appears as a single blue line in the graph in (D). Two-way ANOVA with Bonferroni's multiplecomparison posttest for statistical significance (***P\.001) was used to compare each recipient group at each time point. E-G, To assess the dynamics of engraftment in the marrow after local irradiation, the bioluminescence signal was measured after gating on the left or right hind limb region. Schemas of experimental design are shown to the left of each set of data with i.v. donor cell injection (E), donor cell injection directly into the right irradiated femur (F), and donor cell injection directly into the left (nonirradiated) femur (G). Repeated measurements of bioluminescence were combined for the first 10 days (early) or longer than 10 days (late) post-BMT before applying the paired t test for statistical significance (*P \.05, **P \.01 or NS, not significant) comparing the left and right hind limbs in (E), (F), and (G). All statistical analyses were performed on logarithmic transformation of the data combined from two experiments. IR, irradiation; macs/grans, macrophages/granulocytes; NK, natural killer; NS indicates not statistically significant.
Data from whole-body bioluminescence imaging was consistent with endpoint analysis by FACS. Donor chimerism after intrafemoral injection was again significantly greater with TBI than with local irradiation or no irradiation ( Figure 6D ). Again, the bioluminescence signal was the same in all animals during the first week post-BMT, with the benefits of TBI becoming apparent only after day 8 (P \.001). No difference in overall chimerism between local irradiation and no irradiation was evident ( Figure 6D ).
Bioluminescence Imaging of Locally Irradiated Mice Reveals That the Effects of Irradiation on Hematopoietic Stem Cell Engraftment Are Restricted to the Irradiated Site
Given our finding of high splenic chimerism with and without irradiation, we hypothesized that splenic engraftment would contribute to the whole-body bioluminescence signals seen in both nonirradiated and locally irradiated mice ( Figure 6B and 6D) and thus might obscure chimerism differences specifically in the marrow space. Consequently, we next analyzed the signals arising from the right and left hind limbs separately to assess whether local irradiation would change the dynamics of engraftment specifically in the marrow in the setting of i.v. administered donor cells ( Figure 6E ) or injection of donor cells into the irradiated (right) femur ( Figure 6F ) or the nonirradiated (left) femur ( Figure 6G ). We were interested in examining whether radiation affected not only local engraftment, but also the efficiency of migration to marrow distal to the injection site.
As mentioned earlier, local irradiation had no effect on early donor chimerism in the marrow after i.v. infusion, as demonstrated by identical signals from irradiated and nonirradiated hind limbs during the first week post-BMT ( Figure 6E ). However, a significantly higher (P \.05) signal was detected from the irradiated limb compared with the nonirradiated limb after 1 week ( Figure 6E ).
When bone marrow was injected locally, the signal was statistically higher in the injected limb during the first week post-BMT irrespective of whether the limb injected was on the side that received irradiation ( Figure 6F ; P \.05) or on the side contralateral to irradiation ( Figure 6G ; P \.01). The higher initial donor chimerism in the injected sites was maintained into the later posttransplantation period; however, long-term donor chimerism was greatest in the limbs that received donor cells injected into the irradiated sites. These findings lead us to conclude that the effects of local sublethal irradiation are limited to the irradiated microenvironment rather than induction of systemic factors that can influence distal sites of engraftment.
DISCUSSION
The clinical use of nonmyeloablative preparative regimens for hematopoietic stem cell transplantation continues to increase since the first observations that donor chimerism could be accomplished with significantly reduced toxicity to the recipient. Most of these regimens combine low-dose irradiation, as either TBI or total lymphoid irradiation, with lymphoablative drugs. How low-dose irradiation improves engraftment is not clear, but the main mechanism for this effect is thought to be an increase in host lymphoablation and consequent prevention of immunologic rejection. However, some experimental models suggest that sublethal irradiation improves stem cell engraftment through effects on the marrow microenvironment in a dose-dependent manner [18] . To examine the effects of low-dose irradiation on nonimmunologic mechanisms of engraftment, we analyzed the kinetics of donor engraftment in severely immune-deficient mouse recipients. We found that sublethal TBI significantly increased marrow engraftment after allogeneic BMT independent of any effects on lymphoablation.
The use of bioluminescence imaging revealed that although long-term chimerism is increased by sublethal irradiation, this effect is not a result of increased early engraftment. The increased percentage of donor cells in irradiated bone marrow early post-BMT detected by flow cytometry reflects the rapid loss of host cells after irradiation. In fact, early post BMT, irradiation reduced, rather than increased, the absolute number of donor cells in the host bone marrow. This finding is consistent with the results of previous studies comparing homing and engraftment of donor cells in nonirradiated and lethally irradiated transplant recipients [17, 19, 20] . Damage to stromal cells after irradiation has been shown to decrease the retention of hematopoietic cells in the bone marrow, leading to increased lodgment of donor cells in nonhematopoietic organs, such as the liver, lung, and skeletal muscle, after transplantation [20, 21] . This might explain the equivalent whole-body bioluminescence seen in our imaging studies of irradiated and nonirradiated recipients during the first week post-BMT.
Bioluminescence imaging revealed that expansion of donor cells began $7 days after engraftment and continued for approximately 30 days after BMT. This late expansion was significantly increased with sublethal irradiation. These findings are consistent with the hypothesis that irradiation induces changes in the recipient marrow microenvironment that stimulate donor cell expansion rather than facilitate homing. The finding that local irradiation enhanced long-term chimerism of the irradiated limb, but not of distal sites, suggests that the effect of radiation is limited to the local irradiated microenvironment and is not due to the release of systemic factors. Of note, even in animals that received intrafemoral transplantation, TBI produced higher levels of overall marrow chimerism compared with local irradiation, presumably because of the larger area of marrow space affected by TBI.
Intrafemoral transplantation has been reported to improve engraftment compared with i.v. transplantation in allogeneic [22] and xenogeneic BMT models [5, 22, 23] . However, in the present study, we found that i.v. administration of donor cells produced higher levels of marrow chimerism than intrafemoral administration. Several aspects of our experimental design might explain the discrepancies between our findings and previous reports. Almost all of the data comparing intrafemoral and i.v. transplantation used small numbers of purified human stem and progenitor cells transplanted into immune-deficient mice [5, [24] [25] [26] . It is likely that homing in the xenogeneic model is relatively inefficient, and that direct administration into the marrow space provides an advantage over systemic infusion in the xenogeneic setting. In addition, depletion of T cells and other mature cells from the more purified stem cell grafts used in the previous studies would be expected to further reduce the efficiency of homing and engraftment. In our study, we used unfractionated allogeneic bone marrow rather than purified stem cells, thereby possibly further facilitating engraftment in the i.v. transplantations.
Because whole-body bioluminescence imaging reflects a composite of donor cells circulating from marrow to other lymphohematopoietic organs, we also performed bioluminescence analysis of hind limbs separately to assess chimerism specifically in each marrow space. In mice given TBI, the signal from donor cells was higher at the injected site than in distal sites during the first week post-BMT. However, after the first week, locally injected cells had mobilized to and proliferated in distant sites, eventually leading to long-term systemic chimerism. Thus, although locally injected limbs had high levels of chimerism initially, engraftment at distal sites was delayed compared with that in mice receiving i.v. transplantation.
An interesting study by Ito et al. [10] found that animals receiving locally delivered sublethal irradiation to the mediastinum or hind limbs alone had increased donor chimerism in local and distal sites compared with animals that received no irradiation. The authors suggested that their data supported a model in which local irradiation first induces local proliferation of engrafted donor cells at irradiated sites, which subsequently equilibrate systemically to increase chimerism in nonirradiated sites. That study involved only i.v. administration of donor cells, and thus did not address how cells would respond if injected directly into the irradiated or nonirradiated marrow spaces.
We found that regardless of the injection route, recipients with 2.7 Gy delivered as TBI had significantly higher long-term systemic engraftment compared with recipients receiving 2.7 Gy of local irradiation restricted to the right hind limb. However, again there was no difference in early whole-body bioluminescence in recipients of TBI, local irradiation, and no irradiation. It should be noted that several differences in the experimental design between the study of Ito et al. [10] and the present study might account for the greater effect of local irradiation seen in the former study. Ito et al. used both a higher radiation dose (7 Gy) and a larger exposure area than our study (mediastinal was estimated as 20% of the total marrow space, compared with 7.5% for a single limb, based on data by DR Boggs [27] . In addition, they used a 200-fold higher cell dose than that used in our study.
In summary, the highest levels of long-term chimerism were seen with the combination of TBI and i.v. administration of donor cells. The effect of sublethal irradiation was first detected at least 1 week post-BMT; during the first week, bioluminescence was unaffected by either systemic or local irradiation. These findings indicate that sublethal irradiation most likely increases long-term chimerism through direct effects on the marrow microenvironment that induce proliferation of donor cells, an effect that is enhanced by both systemic administration of donor cells and maximization of the area of irradiation.
